Risk-based selection from the general population in a screening trial: Selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON)

被引:387
作者
van Iersel, Carola A.
de Koning, Harry J.
Draisma, Gerrit
Mali, Willem P. T. M.
Scholten, Ernst Th.
Nackaerts, Kristiaan
Prokop, Mathias
Habbema, J. Dik. F.
Oudkerk, Mathijs
van Klaveren, Rob J.
机构
[1] Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands
[2] Erasmus MC, Dept Pulm, Rotterdam, Netherlands
[3] Univ Utrecht, Ctr Med, Dept Radiol, Utrecht, Netherlands
[4] Kennemer Gasthuis Haarlem, Dept Radiol, Haarlem, Netherlands
[5] Univ Hosp Gasthuisberg, Dept Pulm, Louvain, Belgium
[6] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands
关键词
lung cancer; screening; computed tomography; power; risk estimation;
D O I
10.1002/ijc.22134
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
A method to obtain the optimal selection criteria, taking into account available resources and capacity and the impact on power, is presented for the Dutch-Belgian randomised lung cancer screening trial (NELSON). NELSON investigates whether 16-detector multi-slice computed tomography screening will decrease lung cancer mortality compared to no screening. A questionnaire was sent to 335,441 (mainly) men, aged 50-75. Smoking exposure (years smoked, cigarettes/day, years quit) was determined, and expected lung cancer mortality was estimated for different selection scenarios for the 106,931 respondents, using lung cancer mortality data by level of smoking exposure (US Cancer Prevention Study I and II). Selection criteria were chosen so that the required response among eligible subjects to reach sufficient sample size was minimised and the required sample size was within our capacity. Inviting current and former smokers (quit <= 10 years ago) who smoked > 15 cigarettes/day during > 25 years or > 10 cigarettes/day during > 30 years was most optimal. With a power of 80%, 17,300-27,900 participants are needed to show a 20-25% lung cancer mortality reduction 10 years after randomisation. Until October 18, 2005 11,103 (first recruitment round) and 4,325 (second recruitment round) (total = 15,428) participants have been randomised. Selecting participants for lung cancer screening trials based on risk estimates is feasible and helpful to minimize sample size and costs. When pooling with Danish trial data (n = +/- 4,000) NELSON is the only trial without screening in controls that is expected to have 80% power to show a lung cancer mortality reduction of at least 25% 10 years after randomisation. (c) 2006 Wiley-Liss, Inc.
引用
收藏
页码:868 / 874
页数:7
相关论文
共 37 条
[1]
Alexander FE, 1999, EUR J CANCER, V35, P262
[2]
[Anonymous], SMOKING TOBACCO CONT
[3]
Variations in lung cancer risk among smokers [J].
Bach, PB ;
Kattan, MW ;
Thornquist, MD ;
Kris, MG ;
Tate, RC ;
Barnett, MJ ;
Hsieh, LJ ;
Begg, CB .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (06) :470-478
[4]
Benchmarking lung cancer mortality rates in current and former smokers [J].
Bach, PB ;
Elkin, EB ;
Pastorino, U ;
Kattan, MA ;
Mushlin, AI ;
Begg, CB ;
Parkin, DM .
CHEST, 2004, 126 (06) :1742-1749
[5]
Lung cancer rates in men and women with comparable histories of smoking [J].
Bain, C ;
Feskanich, D ;
Speizer, FE ;
Thun, M ;
Hertzmark, E ;
Rosner, BA ;
Colditz, GA .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (11) :826-834
[6]
*BOARD SCI ADV NAT, 2005, M MIN BETH MD MARCH
[7]
BURNS DM, 1997, SMOKING TOBACCO CONT, V8, P113
[8]
Prostate cancer mortality reduction by screening:: Power and time frame with complete enrollment in the European Randomised Screening for Prostate Cancer (ERSPC) trial [J].
de Koning, HJ ;
Liem, MK ;
Baan, CA ;
Boer, R ;
Schröder, FH ;
Alexander, FE .
INTERNATIONAL JOURNAL OF CANCER, 2002, 98 (02) :268-273
[9]
Screening for early lung cancer with low-dose spiral computed tomography: results of annual follow-up examinations in asymptomatic smokers [J].
Diederich, S ;
Thomas, M ;
Semik, M ;
Lenzen, H ;
Roos, N ;
Weber, A ;
Heindel, W ;
Wormanns, D .
EUROPEAN RADIOLOGY, 2004, 14 (04) :691-702
[10]
Screening for early lung cancer with low-dose spiral CT: Prevalence in 817 asymptomatic smokers [J].
Diederich, S ;
Wormanns, D ;
Semik, M ;
Thomas, M ;
Lenzen, H ;
Roos, N ;
Heindel, W .
RADIOLOGY, 2002, 222 (03) :773-781